A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin

Single Dose Open-label Comparative Pharmacokinetic Study to Assess the Pharmacokinetic Characteristics of Irbesartan and Atorvastatin Between Irbesartan/Atorvastatin Combination Tablet and Coadministration of Irbesartan and Atorvastatin Tablets in Healthy Male Subjects

The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of Irbesartan and Atorvastatin in combination as HCP0912

Inclusion Criteria:

• Age between 20 and 45
• Signed informed consent form
• weight : over 45kg and in the range of ±20% of IBW

Exclusion Criteria:

• Has a medical history of hypersensitivity to atorvastatin or irbesartan
• severe Hypotension
• Not eligible for subject in health examination within 28 days of IP administration